TY - JOUR
T1 - NCCN GUIDELINES® INSIGHTS
T2 - Central Nervous System Cancers, Version 2.2022
AU - Horbinski, Craig
AU - Nabors, Louis Burt
AU - Portnow, Jana
AU - Baehring, Joachim
AU - Bhatia, Ankush
AU - Bloch, Orin
AU - Brem, Steven
AU - Butowski, Nicholas
AU - Cannon, Donald M.
AU - Chao, Samuel
AU - Chheda, Milan G.
AU - Fabiano, Andrew J.
AU - Forsyth, Peter
AU - Gigilio, Pierre
AU - Hattangadi-Gluth, Jona
AU - Holdhoff, Matthias
AU - Junck, Larry
AU - Kaley, Thomas
AU - Merrell, Ryan
AU - Mrugala, Maciej M.
AU - Nagpal, Seema
AU - Nedzi, Lucien A.
AU - Nevel, Kathryn
AU - Nghiemphu, Phioanh L.
AU - Parney, Ian
AU - Patel, Toral R.
AU - Peters, Katherine
AU - Puduvalli, Vinay K.
AU - Rockhill, Jason
AU - Rusthoven, Chad
AU - Shonka, Nicole
AU - Swinnen, Lode J.
AU - Weiss, Stephanie
AU - Wen, Patrick Yung
AU - Willmarth, Nicole E.
AU - Bergman, Mary Anne
AU - Darlow, Susan
N1 - Publisher Copyright:
© 2023 National Comprehensive Cancer Network® (NCCN®), All rights reserved.
PY - 2023/1
Y1 - 2023/1
N2 - The NCCN Guidelines for Central Nervous System (CNS) Cancers focus on management of the following adult CNS cancers: glioma (WHO grade 1, WHO grade 2–3 oligodendroglioma [1p19q codeleted, IDH-mutant], WHO grade 2–4 IDH-mutant astrocytoma, WHO grade 4 glioblastoma), intracranial and spinal ependymomas, medulloblastoma, limited and extensive brain metastases, leptomeningeal metastases, non–AIDS-related primary CNS lymphomas, metastatic spine tumors, meningiomas, and primary spinal cord tumors. The information contained in the algorithms and principles of management sections in the NCCN Guidelines for CNS Cancers are designed to help clinicians navigate through the complex management of patients with CNS tumors. Several important principles guide surgical management and treatment with radiotherapy and systemic therapy for adults with brain tumors. The NCCN CNS Cancers Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights summarize the panel’s most recent recommendations regarding molecular profiling of gliomas.
AB - The NCCN Guidelines for Central Nervous System (CNS) Cancers focus on management of the following adult CNS cancers: glioma (WHO grade 1, WHO grade 2–3 oligodendroglioma [1p19q codeleted, IDH-mutant], WHO grade 2–4 IDH-mutant astrocytoma, WHO grade 4 glioblastoma), intracranial and spinal ependymomas, medulloblastoma, limited and extensive brain metastases, leptomeningeal metastases, non–AIDS-related primary CNS lymphomas, metastatic spine tumors, meningiomas, and primary spinal cord tumors. The information contained in the algorithms and principles of management sections in the NCCN Guidelines for CNS Cancers are designed to help clinicians navigate through the complex management of patients with CNS tumors. Several important principles guide surgical management and treatment with radiotherapy and systemic therapy for adults with brain tumors. The NCCN CNS Cancers Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights summarize the panel’s most recent recommendations regarding molecular profiling of gliomas.
KW - Adult
KW - Brain Neoplasms/diagnosis
KW - Central Nervous System
KW - Central Nervous System Neoplasms/diagnosis
KW - Humans
KW - Mutation
UR - http://www.scopus.com/inward/record.url?scp=85146195028&partnerID=8YFLogxK
U2 - 10.6004/jnccn.2023.0002
DO - 10.6004/jnccn.2023.0002
M3 - Article
C2 - 36634606
AN - SCOPUS:85146195028
SN - 1540-1405
VL - 21
SP - 12
EP - 20
JO - Journal of the National Comprehensive Cancer Network : JNCCN
JF - Journal of the National Comprehensive Cancer Network : JNCCN
IS - 1
ER -
